OAC
IMRX icon

OMERS Administration Corp’s Immuneering IMRX Stock Holding History

OMERS Administration Corp’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118K Sell
22,400
-25,400
-53% -$130K ﹤0.01% 991
2025
Q4 		$315K Buy
+47,800
New +$307K ﹤0.01% 802

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OMERS Administration Corp's IMRX Position: Q1 2026 in Review

OMERS Administration Corp reduced its Immuneering (IMRX) stake by 53% in Q1 2026, selling an estimated $130K and leaving 22,400 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #991.

OMERS Administration Corp first reported a position in IMRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $315K in Q4 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • OMERS Administration Corp held 22,400 shares of Immuneering worth $118K as of Q1 2026.
  • OMERS Administration Corp sold 25,400 Immuneering shares in Q1 2026, an estimated $130K.
  • Immuneering made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #991 holding.
  • OMERS Administration Corp first reported a position in Immuneering in Q4 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's Immuneering position peaked at $315K in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.